Λίστα αντικειμένων
An important paper published in Blood showed that prophylaxis is not
always wihtout harm. Pts under letermovir prophylaxis may be at risk for
late CMV infection after HCT because of delay CMV-specific cellular
reconstitution (which is due to the letermovir induced decreased CMV
antigen exposure).
JOURNAL ARTICLE
Cytomegalovirus-specific T-cell Reconstitution following Letermovir
Prophylaxis after Hematopoietic Cell Transplantation
Danniel Zamora, Elizabeth R Duke, Hu Xie, Bradley C Edmison, Brenda B
Akoto, Richard Kiener, Terry Stevens-Ayers, Ralf Wagner, Marco
Mielcarek, Wendy M Leisenring, Keith R Jerome, Joshua Schiffer, Greg
Finak, Stephen De Rosa, Michael J Boeckh
Blood 2021 March 3
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka
always wihtout harm. Pts under letermovir prophylaxis may be at risk for
late CMV infection after HCT because of delay CMV-specific cellular
reconstitution (which is due to the letermovir induced decreased CMV
antigen exposure).
JOURNAL ARTICLE
Cytomegalovirus-specific T-cell Reconstitution following Letermovir
Prophylaxis after Hematopoietic Cell Transplantation
Danniel Zamora, Elizabeth R Duke, Hu Xie, Bradley C Edmison, Brenda B
Akoto, Richard Kiener, Terry Stevens-Ayers, Ralf Wagner, Marco
Mielcarek, Wendy M Leisenring, Keith R Jerome, Joshua Schiffer, Greg
Finak, Stephen De Rosa, Michael J Boeckh
Blood 2021 March 3
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka